# GO_biological_process_0145

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_biological_process`  
**Author expected answer:** **A** — defense response to bacterium

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MQFKKQLMVIFLAYFLVVNESEAFFGHLFKLATKIIPSLFRRKNQRSRSIMKRDLENLFDPYQRNLELDRLLKQLPNY

[Multiple Choices]
A. defense response to bacterium
B. modulation of process of another organism
C. synaptonemal complex disassembly
D. endocytosis
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Biological Process Prediction, which is to predict the primary biological process a given protein participates in, as defined by the Gene Ontology (GO) 'Biological Process' branch. A biological process is a series of molecular events that accomplishes a larger biological program, such as cell division or signal transduction. Based on the provided protein sequence, you must select the option that best describes the overall biological objective to which the protein contributes.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the archived UniProt record for an antimicrobial peptide. That record reports experimental evidence of activity against multiple bacteria, including membrane disruption, supporting a role in defense response to bacterium. The GO annotation itself is keyword-inferred, while the functional activity is linked to experimental evidence.

Citations as saved: [H3](#evidence-h3), [H4](#evidence-h4), [C5](#evidence-c5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence has a hydrophobic N-terminal region and a basic, likely secreted peptide region, which may suggest an antimicrobial peptide, but those features do not establish its specific biological process.


**Missing item-specific fact**

> The peptide’s experimentally observed antibacterial activity and its identity as marcin-18 are not supplied in the question.


**Reason**

> Selecting the specific process requires knowing this peptide’s functional activity. General sequence features alone do not reliably distinguish defense against bacteria from the broader effect on another organism represented by option B.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> A is the specific process supported by the record. Because the peptide disrupts bacterial membranes, B’s broader description of changing a process in another organism could also apply; the question does not clarify whether it seeks the most specific applicable GO term.


### Important caveats

- The source record is sequence-matched, but the author's exact database snapshot is unknown.
- The experimental functional evidence supports antibacterial activity; the cited GO annotation uses an inferred-evidence code.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has a hydrophobic N-terminal region and a basic, likely secreted peptide region, which may suggest an antimicrobial peptide, but those features do not establish its specific biological process.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The peptide’s experimentally observed antibacterial activity and its identity as marcin-18 are not supplied in the question.",
    "reason": "Selecting the specific process requires knowing this peptide’s functional activity. General sequence features alone do not reliably distinguish defense against bacteria from the broader effect on another organism represented by option B."
  },
  "case_id": "GO_biological_process_0145",
  "expected_answer_check": {
    "evidence_ids": [
      "H3",
      "H4",
      "C5"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the archived UniProt record for an antimicrobial peptide. That record reports experimental evidence of activity against multiple bacteria, including membrane disruption, supporting a role in defense response to bacterium. The GO annotation itself is keyword-inferred, while the functional activity is linked to experimental evidence."
  },
  "important_caveats": [
    "The source record is sequence-matched, but the author's exact database snapshot is unknown.",
    "The experimental functional evidence supports antibacterial activity; the cited GO annotation uses an inferred-evidence code."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "A is the specific process supported by the record. Because the peptide disrupts bacterial membranes, B’s broader description of changing a process in another organism could also apply; the question does not clarify whether it seeks the most specific applicable GO term."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0145",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the archived UniProt record for an antimicrobial peptide. That record reports experimental evidence of activity against multiple bacteria, including membrane disruption, supporting a role in defense response to bacterium. The GO annotation itself is keyword-inferred, while the functional activity is linked to experimental evidence.",
    "evidence_ids": ["H3", "H4", "C5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence has a hydrophobic N-terminal region and a basic, likely secreted peptide region, which may suggest an antimicrobial peptide, but those features do not establish its specific biological process.",
    "missing_item_specific_fact": "The peptide’s experimentally observed antibacterial activity and its identity as marcin-18 are not supplied in the question.",
    "reason": "Selecting the specific process requires knowing this peptide’s functional activity. General sequence features alone do not reliably distinguish defense against bacteria from the broader effect on another organism represented by option B."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "A is the specific process supported by the record. Because the peptide disrupts bacterial membranes, B’s broader description of changing a process in another organism could also apply; the question does not clarify whether it seeks the most specific applicable GO term."
  },
  "important_caveats": [
    "The source record is sequence-matched, but the author's exact database snapshot is unknown.",
    "The experimental functional evidence supports antibacterial activity; the cited GO annotation uses an inferred-evidence code."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt F6K5S6 (sequence matched) identifies the protein as 'Antimicrobial peptide marcin-18' from Olivierus martensii. The FUNCTION comment (ECO:0000269, experimental evidence from PubMed:29896190) describes potent activity against multiple Gram-positive and Gram-negative bacteria via bacterial membrane disruption, with in vivo efficacy in a mouse peritonitis model. The GO annotation GO:0042742 (defense response to bacterium) is assigned with IEA:UniProtKB-KW evidence code, but the underlying functional characterization is experimentally supported. The GO term definition ('Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism') directly matches the described antimicrobial function.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H3](#evidence-h3), [H4](#evidence-h4), [GO3](#evidence-go3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The 78-residue precursor sequence is markedly cationic (numerous Lys and Arg residues, especially in the C-terminal region) and amphipathic (alternating hydrophobic stretches with charged clusters). These are well-established hallmarks of antimicrobial peptides that act by disrupting bacterial membranes. Among the four options, this signature strongly excludes C (synaptonemal complex disassembly) and D (endocytosis), which are unrelated to small cationic peptides. Between A and B, the cationic amphipathic membrane-disrupting mechanism is the canonical mode of antimicrobial peptides, which are specifically annotated under 'defense response to bacterium' (GO:0042742) rather than the broader 'modulation of process of another organism' (GO:0035821). The GO definition of A ('Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism') precisely describes the expected function of a cationic antimicrobial peptide.


**Missing item-specific fact**

> None critical. The cationic/amphipathic sequence signature and general knowledge of antimicrobial peptide biology provide sufficient grounds. Knowing the scorpion-venom origin would confirm but is not strictly required.


**Reason**

> A model with general knowledge of antimicrobial peptide structural signatures (cationic, amphipathic, short) can reason from the sequence to a bactericidal/defense function and select A over the clearly irrelevant C and D. The A-vs-B distinction relies on understanding that antimicrobial peptides are specifically classified under defense response to bacterium rather than the broader interspecies modulation term, which is standard GO annotation practice and general biological knowledge.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "A",
  "B"
]
```

> Option B ('modulation of process of another organism') is a broader GO term that could technically encompass antimicrobial activity since the peptide affects a process in bacteria. However, GO:0042742 is the standard and more specific annotation for antimicrobial peptides, and the experimental evidence (membrane disruption, MIC values against bacteria, in vivo peritonitis model) aligns precisely with the definition of 'defense response to bacterium.' B is not strictly false but is less specific and not the primary annotation. This does not render the question defective since A is the clearly preferred answer.


### Important caveats

- The GO annotation GO:0042742 uses IEA (Inferred from Electronic Annotation) via UniProt keyword, not a direct GO evidence code. However, the underlying functional data (ECO:0000269, experimental) from PubMed:29896190 robustly supports the annotation.
- The sequence provided is the 78-residue precursor; the mature antimicrobial peptide is residues 31-41 (11 aa). The cationic signature is most concentrated in the C-terminal region corresponding to the mature peptide.
- The UniProt entry was first public in Feb 2025; the author's source snapshot is unknown. The historical entry (version 10, released Jan 2026) contains the same annotation.
- The accession F6K5S6 was inferred from dataset image-path metadata (reviewer-only); it was not provided to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The 78-residue precursor sequence is markedly cationic (numerous Lys and Arg residues, especially in the C-terminal region) and amphipathic (alternating hydrophobic stretches with charged clusters). These are well-established hallmarks of antimicrobial peptides that act by disrupting bacterial membranes. Among the four options, this signature strongly excludes C (synaptonemal complex disassembly) and D (endocytosis), which are unrelated to small cationic peptides. Between A and B, the cationic amphipathic membrane-disrupting mechanism is the canonical mode of antimicrobial peptides, which are specifically annotated under 'defense response to bacterium' (GO:0042742) rather than the broader 'modulation of process of another organism' (GO:0035821). The GO definition of A ('Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism') precisely describes the expected function of a cationic antimicrobial peptide.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "None critical. The cationic/amphipathic sequence signature and general knowledge of antimicrobial peptide biology provide sufficient grounds. Knowing the scorpion-venom origin would confirm but is not strictly required.",
    "reason": "A model with general knowledge of antimicrobial peptide structural signatures (cationic, amphipathic, short) can reason from the sequence to a bactericidal/defense function and select A over the clearly irrelevant C and D. The A-vs-B distinction relies on understanding that antimicrobial peptides are specifically classified under defense response to bacterium rather than the broader interspecies modulation term, which is standard GO annotation practice and general biological knowledge."
  },
  "case_id": "GO_biological_process_0145",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H3",
      "H4",
      "GO3"
    ],
    "judgment": "supported",
    "reason": "UniProt F6K5S6 (sequence matched) identifies the protein as 'Antimicrobial peptide marcin-18' from Olivierus martensii. The FUNCTION comment (ECO:0000269, experimental evidence from PubMed:29896190) describes potent activity against multiple Gram-positive and Gram-negative bacteria via bacterial membrane disruption, with in vivo efficacy in a mouse peritonitis model. The GO annotation GO:0042742 (defense response to bacterium) is assigned with IEA:UniProtKB-KW evidence code, but the underlying functional characterization is experimentally supported. The GO term definition ('Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism') directly matches the described antimicrobial function."
  },
  "important_caveats": [
    "The GO annotation GO:0042742 uses IEA (Inferred from Electronic Annotation) via UniProt keyword, not a direct GO evidence code. However, the underlying functional data (ECO:0000269, experimental) from PubMed:29896190 robustly supports the annotation.",
    "The sequence provided is the 78-residue precursor; the mature antimicrobial peptide is residues 31-41 (11 aa). The cationic signature is most concentrated in the C-terminal region corresponding to the mature peptide.",
    "The UniProt entry was first public in Feb 2025; the author's source snapshot is unknown. The historical entry (version 10, released Jan 2026) contains the same annotation.",
    "The accession F6K5S6 was inferred from dataset image-path metadata (reviewer-only); it was not provided to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "A",
      "B"
    ],
    "reason": "Option B ('modulation of process of another organism') is a broader GO term that could technically encompass antimicrobial activity since the peptide affects a process in bacteria. However, GO:0042742 is the standard and more specific annotation for antimicrobial peptides, and the experimental evidence (membrane disruption, MIC values against bacteria, in vivo peritonitis model) aligns precisely with the definition of 'defense response to bacterium.' B is not strictly false but is less specific and not the primary annotation. This does not render the question defective since A is the clearly preferred answer."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0145",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt F6K5S6 (sequence matched) identifies the protein as 'Antimicrobial peptide marcin-18' from Olivierus martensii. The FUNCTION comment (ECO:0000269, experimental evidence from PubMed:29896190) describes potent activity against multiple Gram-positive and Gram-negative bacteria via bacterial membrane disruption, with in vivo efficacy in a mouse peritonitis model. The GO annotation GO:0042742 (defense response to bacterium) is assigned with IEA:UniProtKB-KW evidence code, but the underlying functional characterization is experimentally supported. The GO term definition ('Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism') directly matches the described antimicrobial function.",
    "evidence_ids": ["C1", "C4", "C5", "H3", "H4", "GO3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The 78-residue precursor sequence is markedly cationic (numerous Lys and Arg residues, especially in the C-terminal region) and amphipathic (alternating hydrophobic stretches with charged clusters). These are well-established hallmarks of antimicrobial peptides that act by disrupting bacterial membranes. Among the four options, this signature strongly excludes C (synaptonemal complex disassembly) and D (endocytosis), which are unrelated to small cationic peptides. Between A and B, the cationic amphipathic membrane-disrupting mechanism is the canonical mode of antimicrobial peptides, which are specifically annotated under 'defense response to bacterium' (GO:0042742) rather than the broader 'modulation of process of another organism' (GO:0035821). The GO definition of A ('Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism') precisely describes the expected function of a cationic antimicrobial peptide.",
    "missing_item_specific_fact": "None critical. The cationic/amphipathic sequence signature and general knowledge of antimicrobial peptide biology provide sufficient grounds. Knowing the scorpion-venom origin would confirm but is not strictly required.",
    "reason": "A model with general knowledge of antimicrobial peptide structural signatures (cationic, amphipathic, short) can reason from the sequence to a bactericidal/defense function and select A over the clearly irrelevant C and D. The A-vs-B distinction relies on understanding that antimicrobial peptides are specifically classified under defense response to bacterium rather than the broader interspecies modulation term, which is standard GO annotation practice and general biological knowledge."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["A", "B"],
    "reason": "Option B ('modulation of process of another organism') is a broader GO term that could technically encompass antimicrobial activity since the peptide affects a process in bacteria. However, GO:0042742 is the standard and more specific annotation for antimicrobial peptides, and the experimental evidence (membrane disruption, MIC values against bacteria, in vivo peritonitis model) aligns precisely with the definition of 'defense response to bacterium.' B is not strictly false but is less specific and not the primary annotation. This does not render the question defective since A is the clearly preferred answer."
  },
  "important_caveats": [
    "The GO annotation GO:0042742 uses IEA (Inferred from Electronic Annotation) via UniProt keyword, not a direct GO evidence code. However, the underlying functional data (ECO:0000269, experimental) from PubMed:29896190 robustly supports the annotation.",
    "The sequence provided is the 78-residue precursor; the mature antimicrobial peptide is residues 31-41 (11 aa). The cationic signature is most concentrated in the C-terminal region corresponding to the mature peptide.",
    "The UniProt entry was first public in Feb 2025; the author's source snapshot is unknown. The historical entry (version 10, released Jan 2026) contains the same annotation.",
    "The accession F6K5S6 was inferred from dataset image-path metadata (reviewer-only); it was not provided to the evaluated model."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `F6K5S6` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 10. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/F6K5S6.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:15.245104+00:00.  

```json
"F6K5S6"
```

Source SHA-256: `0e2af06e53ab0532a27874d9c775be538bb77c2a55cb7cf37588f4d37ddb6dd0`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/F6K5S6.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:15.245104+00:00.  

```json
{"flag":"Precursor","recommendedName":{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"29896190","source":"PubMed"}],"value":"Antimicrobial peptide marcin-18"}}}
```

Source SHA-256: `0e2af06e53ab0532a27874d9c775be538bb77c2a55cb7cf37588f4d37ddb6dd0`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/F6K5S6.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:15.245104+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"29896190","source":"PubMed"}],"value":"Antimicrobial peptide with potent activity against bacteria. Acts by fastly disrupting the bacterial membrane. Shows activity against Gram-positive bacteria S.aureus (MIC=1.5-2.9 uM) and S.epidermidis (MIC=2.9 uM), M.luteus (MIC=23.4 uM), B.thuringiensis (MIC=2.9 uM), B.subtilis (MIC=2.9 uM) and Gram-negative bacteria E.coli (MIC=5.9-11.7 uM) and P.aeruginosa (MIC=5.9 uM), as well as against penicillin (MIC=2.9 uM) and methicillin (MIC=1.5-2.9 uM) resistant bacteria. Antibiotic activity is not affected by major negatively charged components of the prokaryotic cell wall (e.g. lipopolysaccharides and lipoteichoic acid). In vivo, in a mouse model of lethal peritonitis, shows potent antibiotic activity without cytotoxicity, improving the survival rate"}]}
```

Source SHA-256: `0e2af06e53ab0532a27874d9c775be538bb77c2a55cb7cf37588f4d37ddb6dd0`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/F6K5S6?format=txt&versions=10)  
**Locator:** `lines 42-54`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 10 / 1.  
**Retrieved:** 2026-11-02T04:28:18.617653+00:00.  

```text
CC   -!- FUNCTION: Antimicrobial peptide with potent activity against bacteria.
CC       Acts by fastly disrupting the bacterial membrane. Shows activity
CC       against Gram-positive bacteria S.aureus (MIC=1.5-2.9 uM) and
CC       S.epidermidis (MIC=2.9 uM), M.luteus (MIC=23.4 uM), B.thuringiensis
CC       (MIC=2.9 uM), B.subtilis (MIC=2.9 uM) and Gram-negative bacteria E.coli
CC       (MIC=5.9-11.7 uM) and P.aeruginosa (MIC=5.9 uM), as well as against
CC       penicillin (MIC=2.9 uM) and methicillin (MIC=1.5-2.9 uM) resistant
CC       bacteria. Antibiotic activity is not affected by major negatively
CC       charged components of the prokaryotic cell wall (e.g.
CC       lipopolysaccharides and lipoteichoic acid). In vivo, in a mouse model
CC       of lethal peritonitis, shows potent antibiotic activity without
CC       cytotoxicity, improving the survival rate.
CC       {ECO:0000269|PubMed:29896190}.
```

Source SHA-256: `d3e33b1213622427b6ee88bca39ec4fa6cf32de4466e1147747325f78a3ee193`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/F6K5S6?format=txt&versions=10)  
**Locator:** `lines 77-77`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 10 / 1.  
**Retrieved:** 2026-11-02T04:28:18.617653+00:00.  

```text
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
```

Source SHA-256: `d3e33b1213622427b6ee88bca39ec4fa6cf32de4466e1147747325f78a3ee193`.

### Evidence GO3

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)  
**Locator:** `lines 240383-240399`  
**Scope:** current ontology; exact historical benchmark ontology unknown.  
**Retrieved:** 2026-11-01T07:04:24.975173+00:00.  

```text
[Term]
id: GO:0042742
name: defense response to bacterium
namespace: biological_process
alt_id: GO:0009816
alt_id: GO:0042830
def: "Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism." [GOC:jl]
synonym: "antibacterial peptide activity" RELATED []
synonym: "defence response to bacteria" EXACT []
synonym: "defence response to bacterium" EXACT []
synonym: "defense response to bacteria" EXACT []
synonym: "defense response to bacterium, incompatible interaction" NARROW []
synonym: "resistance response to pathogenic bacteria" NARROW []
synonym: "resistance response to pathogenic bacterium" NARROW []
is_a: GO:0006952 ! defense response
is_a: GO:0009617 ! response to bacterium

```

Source SHA-256: `b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_biological_process.json), zero-based source row 145. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
